Paricalcitol 1mcg, 2mcg; soft gel caps. Take without regard to food. <10yrs: not established. 10–16yrs: CKD Stages 3/4: initially 1mcg 3 times weekly (no more often than every other day). CKD Stage 5: ...

Paricalcitol 2mcg/mL, 5mcg/mL; soln for IV inj; contains alcohol. Give as IV bolus inj during dialysis. Initially 0.04–0.1mcg/kg (2.8–7mcg) no more often than every other day; may increase in ...

This study evaluated the health-economic consequences of use of intravenous paricalcitol (Zemplar ®), oral calcitriol or oral and intravenous alfacalcidol for the treatment of patients with secondary ...

JERUSALEM — Generic drug maker Teva Pharmaceutical Industries has launched a version of a drug used to treat a parathyroid disorder related to kidney disease. Teva announced Tuesday the launch of ...

Abbott Park, IL - Abbott Laboratories announced Friday it has received FDA approval for a capsule form of paricalcitol (Zemplar) for the prevention and treatment of secondary hyperparathyroidism (SHPT ...

Abbott Laboratories is celebrating winning US Food and Drug Administration approval for Zemplar Capsules (paricalcitol) for both the prevention and treatment of secondary hyperparathyroidism – a ...

A drug designed to mimic the effects of Vitamin D hormone may be able to boost the effectiveness of radiation treatment for prostate cancer, report researchers from Wake Forest University Baptist ...

> Two senior Republican lawmakers have come out in favor of opposition by the generic drug industry to a proposed FDA rule that would have them change labels on products if they receive new safety ...

Review the side-effects of Paricalcitol as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...

NEW YORK (MarketWatch) -- Abbott Laboratories said Friday that the Food and Drug Administration approved for sale a capsule form of its Zemplar kidney drug. The drug, which is used to prevent and ...

New Delhi, Sep 19: Drug firm Dr Reddy's Laboratories today said it has launched in the US generic Paricalcitol injection used for treatment associated with chronic kidney disease. It has launched the ...

AbbVie Inc., the drug unit that split from parent Abbott Laboratories on Jan. 1, sued Indian generic drugmaker Sun Pharmaceutical Industries Ltd. for infringing a patent for Zemplar, used to treat ...